Lv3
358 积分 2022-02-14 加入
A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy
3小时前
待确认
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy
3小时前
待确认
Complement activation and effector pathways in membranous nephropathy
3小时前
已完结
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
3小时前
已完结
GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes
1天前
已完结
Learning from Negative Trials for Diabetic Kidney Disease
2天前
求助中
The key role of altered tubule cell lipid metabolism in kidney disease development
3天前
已完结
Immunometabolic rewiring of tubular epithelial cells in kidney disease
3天前
已完结
Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
7天前
已完结
Treating Reproductive-Aged Women With Glucagon-Like Peptide-1 Receptor Agonists: What Are the Clinical Considerations?
11天前
已完结
皖公网安备34019202002308
